🦊/Investors

Sorin InvestmentsFull Portfolio

5 tracked investments · listed companies and verified rows first

Aivaraivar.techinJun 2026 · $4.6M

Aivar provides technology solutions with team members bringing expertise in technology, strategy, sales, and industry knowledge.

AI & Machine LearningEnterprise SoftwareSaaSSector AgnosticMenlo Park, US

Praveen Jayakumar(Founder)in

Co-investorsBessemer Venture Partners

Enmovilenmovil.aiinAug 2025 · $6M

Enmovil builds an AI intelligence layer that sits over enterprises' existing ERP, TMS, and WMS systems to unify data and make operational supply-chain decisions—such as dispatch, load-matching, inventory repositioning, and carrier selection—delivered through chat or voice in tools like Teams, Slack, and Excel.

AI & Machine LearningEnterprise SoftwareLogistics & Supply Chain

Nanda Dharmavaram(Founder)in

Co-investorsAnicut CapitalCapria Ventures

Freedgetfreed.aiFeb 2026 · $6.6M

Freed builds an AI assistant for clinicians that generates clinical notes from patient encounters, offering customizable templates, visit prep summaries, patient-friendly instructions, referral and other letters, and suggested billable ICD-10, CPT, and E/M codes that can sync to an EHR.

AI & Machine LearningDigital HealthHealthtechSan Francisco, US

Erez Druk(CEO & Co-founder)Andrey Bannikov(Founder)in

Co-investorsScale Venture PartnersSequoia Capital

Nivaan Carenivaancare.cominJan 2026 · $7M

Nivaan is India's largest centre for interventional pain management and regenerative medicine, offering integrated, non-surgical care for musculoskeletal and chronic pain through coordinated multidisciplinary teams of specialists, physiotherapists, and care managers.

Digital HealthHealthtechMedical DevicesGurgaon, IN

Nivesh KhandelwalinVishwas Singhin

Co-investorsRebright PartnersW Health Ventures Gp LlcEndiya Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Uniqus Consultech

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.